WAYS TO IMPROVE THE RESULTS OF SURGICAL TREATMENT OF DIFFUSE TOXIC GOITTER

Nishanov M.F.; Aliboev M.R.; Usmanov Kh.A.; Abdurakhmadov A.A.

doi:10.5281/zenodo.11080003

Nishanov M.F., Aliboev M.R., Usmanov Kh.A., Abdurakhmadov A.A.

Abstract. In the given article the authors analyze that an improved method of surgical access to the thyroid jelly and a postoperative rehabilitation program can reduce the incidence of long-term complications. The authors conclude that the use of an improved method of surgical treatment of thyroid jelly and a post-volitional rehabilitation program made it possible to reduce the incidence of long-term complications, which in the village ensured a clearing of the proportion of good and satisfactory results from 84.7% to 97.3% with a decrease in the likelihood of an unsatisfactory outcome with 15.3% - 2.7%.

Keywords: strumectomy, thyroid gland, hypothyroidism, hypoparathyroidism, diffuse toxic goiter.

References:

1. Dedov, I.I. Endocrinology // – M.: GEOTAR-Media, 2008. – 432 p. 2. Kochergina, I.I. Diffuse toxic goiter // Therapy. – 2015. – N. 4(4). – P. 6-11. 3. Solodky, V.A. High-dose radioiodine therapy for Graves' disease // Bulletin of the Russian Scientific Center of Radiology of the Ministry of Health of Russia. – 2013. – T. 4. – N. 13. – P. 11 4. Troshina, E.A. Principles of thyreostatic therapy for Graves' disease (lecture) // Consilium medicum. – 2012. – T. 12. – N. 12. – P. 64-68. 5. Tsurkan, A.Yu. Assessment of the influence of various factors on the outcome of subtotal resection of the thyroid gland in Graves' disease // Clinical and experimental thyroidology. – 2011. – T. 7. – N. 1. – P. 50-54. 6. Sheremeta, M.S. Clinical course of endocrine ophthalmopathy in Graves’ disease depending on the effect of radioiodine therapy // Problems of endocrinology. – 2011. – N. 3. – P. 17–20. 7. Aoki, Y. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey // Thyroid. – 2007. – Vol. 17. – P. 1211-1223. 8. Gullo, D. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients // PLoS One. – 2011. – Vol. 6. – Is. 8. – e22552. – P. 1-7. 9. Hovens, G.C.J. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with, de novo Graves disease // Clin. Endocrinol. – 2006. – N. 4. – P. 429-435. 10. Noguchi, H. Surgical management of Grave’s disease, past and future // 12th Congress of Asian Association of Endocrine Surgeons, 2010. – March 23–24.